|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| Direct premiums written | |||||
| Change in unearned premium | |||||
| Direct premium earned | |||||
| Ceded premium earned | |||||
| Premiums earned, net | |||||
| Net investment income | |||||
| Net realized gains (losses) on investments | |||||
| Net change in unrealized gains (losses) on investments | |||||
| Commission revenue | |||||
| Policy fees | |||||
| Other revenue | |||||
| Total revenues | |||||
| OPERATING COSTS AND EXPENSES | |||||
| Losses and loss adjustment expenses | |||||
| General and administrative expenses | |||||
| Policy acquisition costs | |||||
| Other operating costs and expenses | |||||
| Total operating costs and expenses | |||||
| Interest and amortization of debt issuance costs | |||||
| INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT) | |||||
| Income tax expense (benefit) | |||||
| NET INCOME (LOSS) | |||||
| Basic earnings (loss) per common share (in USD per share) | |||||
| Weighted average common shares outstanding - Basic (in shares) | |||||
| Diluted earnings (loss) per common share (in USD per share) | |||||
| Weighted average common shares outstanding - Diluted (in shares) | |||||
| Cash dividend declared per common share (in USD per share) |
Loading...
